nodes	percent_of_prediction	percent_of_DWPC	metapath
Granisetron—HTR3A—vagus nerve—esophageal cancer	0.0398	0.57	CbGeAlD
Granisetron—Coma hepatic—Capecitabine—esophageal cancer	0.0329	0.0755	CcSEcCtD
Granisetron—Generalised oedema—Cisplatin—esophageal cancer	0.00942	0.0216	CcSEcCtD
Granisetron—Infection—Carboplatin—esophageal cancer	0.00677	0.0155	CcSEcCtD
Granisetron—Liver injury—Cisplatin—esophageal cancer	0.00666	0.0153	CcSEcCtD
Granisetron—Ileus—Capecitabine—esophageal cancer	0.00584	0.0134	CcSEcCtD
Granisetron—Pain—Carboplatin—esophageal cancer	0.00583	0.0134	CcSEcCtD
Granisetron—Hiccups—Cisplatin—esophageal cancer	0.00561	0.0128	CcSEcCtD
Granisetron—Hepatocellular injury—Cisplatin—esophageal cancer	0.00561	0.0128	CcSEcCtD
Granisetron—Body temperature increased—Carboplatin—esophageal cancer	0.00539	0.0124	CcSEcCtD
Granisetron—Fluid retention—Cisplatin—esophageal cancer	0.00532	0.0122	CcSEcCtD
Granisetron—Ventricular extrasystoles—Capecitabine—esophageal cancer	0.00457	0.0105	CcSEcCtD
Granisetron—Hyperbilirubinaemia—Capecitabine—esophageal cancer	0.00454	0.0104	CcSEcCtD
Granisetron—HTR3A—digestive system—esophageal cancer	0.00452	0.0647	CbGeAlD
Granisetron—Hiccups—Capecitabine—esophageal cancer	0.00413	0.00947	CcSEcCtD
Granisetron—Hyponatraemia—Cisplatin—esophageal cancer	0.00408	0.00936	CcSEcCtD
Granisetron—Gastrointestinal haemorrhage—Cisplatin—esophageal cancer	0.00407	0.00932	CcSEcCtD
Granisetron—Melaena—Capecitabine—esophageal cancer	0.00404	0.00925	CcSEcCtD
Granisetron—Urinary incontinence—Capecitabine—esophageal cancer	0.00399	0.00914	CcSEcCtD
Granisetron—Fluid retention—Capecitabine—esophageal cancer	0.00392	0.00899	CcSEcCtD
Granisetron—HTR3A—lung—esophageal cancer	0.00377	0.0541	CbGeAlD
Granisetron—Orthostatic hypotension—Cisplatin—esophageal cancer	0.00372	0.00852	CcSEcCtD
Granisetron—Hypokalaemia—Cisplatin—esophageal cancer	0.0037	0.00849	CcSEcCtD
Granisetron—Aspartate aminotransferase increased—Cisplatin—esophageal cancer	0.00366	0.0084	CcSEcCtD
Granisetron—Abnormal vision—Capecitabine—esophageal cancer	0.0036	0.00826	CcSEcCtD
Granisetron—Photosensitivity—Capecitabine—esophageal cancer	0.00342	0.00783	CcSEcCtD
Granisetron—Hyperbilirubinaemia—Methotrexate—esophageal cancer	0.00338	0.00775	CcSEcCtD
Granisetron—Oliguria—Methotrexate—esophageal cancer	0.00334	0.00765	CcSEcCtD
Granisetron—Hepatic enzyme increased—Methotrexate—esophageal cancer	0.00325	0.00745	CcSEcCtD
Granisetron—Atrial fibrillation—Capecitabine—esophageal cancer	0.00316	0.00725	CcSEcCtD
Granisetron—CYP1A1—epithelium—esophageal cancer	0.00302	0.0433	CbGeAlD
Granisetron—Hyponatraemia—Capecitabine—esophageal cancer	0.00301	0.0069	CcSEcCtD
Granisetron—Melaena—Methotrexate—esophageal cancer	0.003	0.00689	CcSEcCtD
Granisetron—Gastrointestinal haemorrhage—Capecitabine—esophageal cancer	0.003	0.00687	CcSEcCtD
Granisetron—CYP1A1—bronchus—esophageal cancer	0.00298	0.0427	CbGeAlD
Granisetron—Hepatobiliary disease—Cisplatin—esophageal cancer	0.00297	0.0068	CcSEcCtD
Granisetron—Migraine—Capecitabine—esophageal cancer	0.00295	0.00677	CcSEcCtD
Granisetron—Bradycardia—Cisplatin—esophageal cancer	0.00287	0.00657	CcSEcCtD
Granisetron—Coma—Methotrexate—esophageal cancer	0.00281	0.00644	CcSEcCtD
Granisetron—Liver function test abnormal—Capecitabine—esophageal cancer	0.00277	0.00635	CcSEcCtD
Granisetron—Connective tissue disorder—Cisplatin—esophageal cancer	0.00277	0.00634	CcSEcCtD
Granisetron—Orthostatic hypotension—Capecitabine—esophageal cancer	0.00274	0.00628	CcSEcCtD
Granisetron—Hypokalaemia—Capecitabine—esophageal cancer	0.00273	0.00626	CcSEcCtD
Granisetron—Visual impairment—Cisplatin—esophageal cancer	0.00271	0.00622	CcSEcCtD
Granisetron—Aspartate aminotransferase increased—Capecitabine—esophageal cancer	0.0027	0.00619	CcSEcCtD
Granisetron—CYP1A1—trachea—esophageal cancer	0.00267	0.0383	CbGeAlD
Granisetron—Alanine aminotransferase increased—Capecitabine—esophageal cancer	0.00265	0.00606	CcSEcCtD
Granisetron—Flushing—Cisplatin—esophageal cancer	0.00261	0.00599	CcSEcCtD
Granisetron—Abdominal distension—Capecitabine—esophageal cancer	0.00261	0.00598	CcSEcCtD
Granisetron—Photosensitivity—Methotrexate—esophageal cancer	0.00254	0.00583	CcSEcCtD
Granisetron—Angina pectoris—Capecitabine—esophageal cancer	0.00252	0.00579	CcSEcCtD
Granisetron—Arrhythmia—Cisplatin—esophageal cancer	0.00251	0.00576	CcSEcCtD
Granisetron—Alopecia—Cisplatin—esophageal cancer	0.00249	0.0057	CcSEcCtD
Granisetron—Malnutrition—Cisplatin—esophageal cancer	0.00245	0.00562	CcSEcCtD
Granisetron—Dysuria—Capecitabine—esophageal cancer	0.00242	0.00556	CcSEcCtD
Granisetron—Flatulence—Cisplatin—esophageal cancer	0.00241	0.00553	CcSEcCtD
Granisetron—Photosensitivity reaction—Capecitabine—esophageal cancer	0.00237	0.00542	CcSEcCtD
Granisetron—CYP1A1—digestive system—esophageal cancer	0.0023	0.033	CbGeAlD
Granisetron—Tremor—Cisplatin—esophageal cancer	0.0023	0.00526	CcSEcCtD
Granisetron—Ill-defined disorder—Cisplatin—esophageal cancer	0.00227	0.00521	CcSEcCtD
Granisetron—Anaemia—Cisplatin—esophageal cancer	0.00226	0.00519	CcSEcCtD
Granisetron—Jaundice—Capecitabine—esophageal cancer	0.00225	0.00516	CcSEcCtD
Granisetron—CYP3A5—digestive system—esophageal cancer	0.00225	0.0322	CbGeAlD
Granisetron—Urinary tract infection—Capecitabine—esophageal cancer	0.00225	0.00515	CcSEcCtD
Granisetron—Malaise—Cisplatin—esophageal cancer	0.00221	0.00506	CcSEcCtD
Granisetron—Leukopenia—Cisplatin—esophageal cancer	0.00219	0.00503	CcSEcCtD
Granisetron—Hepatobiliary disease—Capecitabine—esophageal cancer	0.00219	0.00501	CcSEcCtD
Granisetron—Epistaxis—Capecitabine—esophageal cancer	0.00218	0.005	CcSEcCtD
Granisetron—Bradycardia—Capecitabine—esophageal cancer	0.00211	0.00484	CcSEcCtD
Granisetron—Rhinitis—Capecitabine—esophageal cancer	0.00208	0.00477	CcSEcCtD
Granisetron—Anxiety—Cisplatin—esophageal cancer	0.00208	0.00476	CcSEcCtD
Granisetron—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.00207	0.00475	CcSEcCtD
Granisetron—Liver function test abnormal—Methotrexate—esophageal cancer	0.00206	0.00472	CcSEcCtD
Granisetron—Discomfort—Cisplatin—esophageal cancer	0.00206	0.00472	CcSEcCtD
Granisetron—Connective tissue disorder—Capecitabine—esophageal cancer	0.00204	0.00467	CcSEcCtD
Granisetron—Anaphylactic shock—Cisplatin—esophageal cancer	0.002	0.00458	CcSEcCtD
Granisetron—Oedema—Cisplatin—esophageal cancer	0.002	0.00458	CcSEcCtD
Granisetron—Visual impairment—Capecitabine—esophageal cancer	0.002	0.00458	CcSEcCtD
Granisetron—Infection—Cisplatin—esophageal cancer	0.00199	0.00455	CcSEcCtD
Granisetron—Nervous system disorder—Cisplatin—esophageal cancer	0.00196	0.00449	CcSEcCtD
Granisetron—Thrombocytopenia—Cisplatin—esophageal cancer	0.00196	0.00449	CcSEcCtD
Granisetron—Tachycardia—Cisplatin—esophageal cancer	0.00195	0.00447	CcSEcCtD
Granisetron—Skin disorder—Cisplatin—esophageal cancer	0.00194	0.00445	CcSEcCtD
Granisetron—Hyperhidrosis—Cisplatin—esophageal cancer	0.00193	0.00443	CcSEcCtD
Granisetron—Flushing—Capecitabine—esophageal cancer	0.00193	0.00441	CcSEcCtD
Granisetron—CYP1A1—lung—esophageal cancer	0.00192	0.0275	CbGeAlD
Granisetron—Eosinophilia—Methotrexate—esophageal cancer	0.00191	0.00438	CcSEcCtD
Granisetron—Angiopathy—Capecitabine—esophageal cancer	0.00188	0.00431	CcSEcCtD
Granisetron—CYP3A5—lung—esophageal cancer	0.00188	0.0269	CbGeAlD
Granisetron—Hypotension—Cisplatin—esophageal cancer	0.00187	0.00428	CcSEcCtD
Granisetron—Chills—Capecitabine—esophageal cancer	0.00186	0.00427	CcSEcCtD
Granisetron—Arrhythmia—Capecitabine—esophageal cancer	0.00185	0.00425	CcSEcCtD
Granisetron—Alopecia—Capecitabine—esophageal cancer	0.00183	0.0042	CcSEcCtD
Granisetron—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.00182	0.00418	CcSEcCtD
Granisetron—Malnutrition—Capecitabine—esophageal cancer	0.00181	0.00414	CcSEcCtD
Granisetron—Dysuria—Methotrexate—esophageal cancer	0.0018	0.00414	CcSEcCtD
Granisetron—Paraesthesia—Cisplatin—esophageal cancer	0.0018	0.00412	CcSEcCtD
Granisetron—Dyspnoea—Cisplatin—esophageal cancer	0.00178	0.00409	CcSEcCtD
Granisetron—Flatulence—Capecitabine—esophageal cancer	0.00178	0.00408	CcSEcCtD
Granisetron—Dysgeusia—Capecitabine—esophageal cancer	0.00177	0.00405	CcSEcCtD
Granisetron—Photosensitivity reaction—Methotrexate—esophageal cancer	0.00176	0.00404	CcSEcCtD
Granisetron—Decreased appetite—Cisplatin—esophageal cancer	0.00174	0.00398	CcSEcCtD
Granisetron—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.00173	0.00396	CcSEcCtD
Granisetron—Pain—Cisplatin—esophageal cancer	0.00171	0.00392	CcSEcCtD
Granisetron—Tremor—Capecitabine—esophageal cancer	0.00169	0.00388	CcSEcCtD
Granisetron—CYP3A4—digestive system—esophageal cancer	0.00169	0.0242	CbGeAlD
Granisetron—Ill-defined disorder—Capecitabine—esophageal cancer	0.00168	0.00384	CcSEcCtD
Granisetron—Anaemia—Capecitabine—esophageal cancer	0.00167	0.00383	CcSEcCtD
Granisetron—CYP2D6—digestive system—esophageal cancer	0.00166	0.0238	CbGeAlD
Granisetron—Sweating—Methotrexate—esophageal cancer	0.00165	0.00378	CcSEcCtD
Granisetron—Feeling abnormal—Cisplatin—esophageal cancer	0.00165	0.00378	CcSEcCtD
Granisetron—Malaise—Capecitabine—esophageal cancer	0.00163	0.00373	CcSEcCtD
Granisetron—Hepatobiliary disease—Methotrexate—esophageal cancer	0.00163	0.00373	CcSEcCtD
Granisetron—Epistaxis—Methotrexate—esophageal cancer	0.00162	0.00372	CcSEcCtD
Granisetron—Vertigo—Capecitabine—esophageal cancer	0.00162	0.00372	CcSEcCtD
Granisetron—Syncope—Capecitabine—esophageal cancer	0.00162	0.00371	CcSEcCtD
Granisetron—Leukopenia—Capecitabine—esophageal cancer	0.00162	0.00371	CcSEcCtD
Granisetron—Palpitations—Capecitabine—esophageal cancer	0.0016	0.00366	CcSEcCtD
Granisetron—Loss of consciousness—Capecitabine—esophageal cancer	0.00159	0.00364	CcSEcCtD
Granisetron—Body temperature increased—Cisplatin—esophageal cancer	0.00158	0.00362	CcSEcCtD
Granisetron—Cough—Capecitabine—esophageal cancer	0.00158	0.00361	CcSEcCtD
Granisetron—Hypertension—Capecitabine—esophageal cancer	0.00156	0.00357	CcSEcCtD
Granisetron—Arthralgia—Capecitabine—esophageal cancer	0.00154	0.00352	CcSEcCtD
Granisetron—Chest pain—Capecitabine—esophageal cancer	0.00154	0.00352	CcSEcCtD
Granisetron—Anxiety—Capecitabine—esophageal cancer	0.00153	0.00351	CcSEcCtD
Granisetron—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.00153	0.0035	CcSEcCtD
Granisetron—Discomfort—Capecitabine—esophageal cancer	0.00152	0.00348	CcSEcCtD
Granisetron—Dry mouth—Capecitabine—esophageal cancer	0.0015	0.00345	CcSEcCtD
Granisetron—Visual impairment—Methotrexate—esophageal cancer	0.00149	0.00341	CcSEcCtD
Granisetron—Oedema—Capecitabine—esophageal cancer	0.00147	0.00338	CcSEcCtD
Granisetron—Hypersensitivity—Cisplatin—esophageal cancer	0.00147	0.00338	CcSEcCtD
Granisetron—Infection—Capecitabine—esophageal cancer	0.00146	0.00336	CcSEcCtD
Granisetron—Shock—Capecitabine—esophageal cancer	0.00145	0.00332	CcSEcCtD
Granisetron—Nervous system disorder—Capecitabine—esophageal cancer	0.00145	0.00331	CcSEcCtD
Granisetron—Thrombocytopenia—Capecitabine—esophageal cancer	0.00144	0.00331	CcSEcCtD
Granisetron—Tachycardia—Capecitabine—esophageal cancer	0.00144	0.0033	CcSEcCtD
Granisetron—Asthenia—Cisplatin—esophageal cancer	0.00143	0.00329	CcSEcCtD
Granisetron—Skin disorder—Capecitabine—esophageal cancer	0.00143	0.00328	CcSEcCtD
Granisetron—Hyperhidrosis—Capecitabine—esophageal cancer	0.00142	0.00327	CcSEcCtD
Granisetron—Angiopathy—Methotrexate—esophageal cancer	0.0014	0.00321	CcSEcCtD
Granisetron—Chills—Methotrexate—esophageal cancer	0.00139	0.00318	CcSEcCtD
Granisetron—Hypotension—Capecitabine—esophageal cancer	0.00138	0.00316	CcSEcCtD
Granisetron—Diarrhoea—Cisplatin—esophageal cancer	0.00137	0.00314	CcSEcCtD
Granisetron—Alopecia—Methotrexate—esophageal cancer	0.00136	0.00313	CcSEcCtD
Granisetron—Malnutrition—Methotrexate—esophageal cancer	0.00134	0.00308	CcSEcCtD
Granisetron—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.00134	0.00308	CcSEcCtD
Granisetron—Insomnia—Capecitabine—esophageal cancer	0.00133	0.00306	CcSEcCtD
Granisetron—Paraesthesia—Capecitabine—esophageal cancer	0.00132	0.00303	CcSEcCtD
Granisetron—CYP3A5—Biological oxidations—ADH1B—esophageal cancer	0.00132	0.00267	CbGpPWpGaD
Granisetron—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—esophageal cancer	0.00132	0.00267	CbGpPWpGaD
Granisetron—Dysgeusia—Methotrexate—esophageal cancer	0.00132	0.00302	CcSEcCtD
Granisetron—Dyspnoea—Capecitabine—esophageal cancer	0.00131	0.00301	CcSEcCtD
Granisetron—CYP1A1—lymph node—esophageal cancer	0.00131	0.0188	CbGeAlD
Granisetron—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—esophageal cancer	0.00131	0.00265	CbGpPWpGaD
Granisetron—Dyspepsia—Capecitabine—esophageal cancer	0.0013	0.00297	CcSEcCtD
Granisetron—Decreased appetite—Capecitabine—esophageal cancer	0.00128	0.00294	CcSEcCtD
Granisetron—HTR3A—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.00128	0.00258	CbGpPWpGaD
Granisetron—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.00127	0.00292	CcSEcCtD
Granisetron—Vomiting—Cisplatin—esophageal cancer	0.00127	0.00291	CcSEcCtD
Granisetron—Rash—Cisplatin—esophageal cancer	0.00126	0.00289	CcSEcCtD
Granisetron—Constipation—Capecitabine—esophageal cancer	0.00126	0.00289	CcSEcCtD
Granisetron—Pain—Capecitabine—esophageal cancer	0.00126	0.00289	CcSEcCtD
Granisetron—Dermatitis—Cisplatin—esophageal cancer	0.00126	0.00289	CcSEcCtD
Granisetron—CYP1A1—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.00125	0.00254	CbGpPWpGaD
Granisetron—CYP3A5—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.00125	0.00253	CbGpPWpGaD
Granisetron—Ill-defined disorder—Methotrexate—esophageal cancer	0.00125	0.00286	CcSEcCtD
Granisetron—CYP1A1—Biological oxidations—ADH1B—esophageal cancer	0.00125	0.00252	CbGpPWpGaD
Granisetron—CYP2D6—Phase 1 - Functionalization of compounds—ALDH2—esophageal cancer	0.00124	0.00252	CbGpPWpGaD
Granisetron—Anaemia—Methotrexate—esophageal cancer	0.00124	0.00285	CcSEcCtD
Granisetron—CYP3A4—Tryptophan metabolism—ALDH2—esophageal cancer	0.00124	0.00251	CbGpPWpGaD
Granisetron—CYP3A5—Biological oxidations—CYP26A1—esophageal cancer	0.00123	0.00248	CbGpPWpGaD
Granisetron—Feeling abnormal—Capecitabine—esophageal cancer	0.00121	0.00278	CcSEcCtD
Granisetron—Malaise—Methotrexate—esophageal cancer	0.00121	0.00278	CcSEcCtD
Granisetron—CYP3A5—Metapathway biotransformation—CYP26A1—esophageal cancer	0.00121	0.00245	CbGpPWpGaD
Granisetron—Vertigo—Methotrexate—esophageal cancer	0.00121	0.00277	CcSEcCtD
Granisetron—Gastrointestinal pain—Capecitabine—esophageal cancer	0.00121	0.00276	CcSEcCtD
Granisetron—Leukopenia—Methotrexate—esophageal cancer	0.0012	0.00276	CcSEcCtD
Granisetron—Nausea—Cisplatin—esophageal cancer	0.00119	0.00272	CcSEcCtD
Granisetron—CYP1A1—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.00118	0.00239	CbGpPWpGaD
Granisetron—Cough—Methotrexate—esophageal cancer	0.00117	0.00269	CcSEcCtD
Granisetron—Urticaria—Capecitabine—esophageal cancer	0.00117	0.00268	CcSEcCtD
Granisetron—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A6—esophageal cancer	0.00117	0.00237	CbGpPWpGaD
Granisetron—Abdominal pain—Capecitabine—esophageal cancer	0.00117	0.00267	CcSEcCtD
Granisetron—Body temperature increased—Capecitabine—esophageal cancer	0.00117	0.00267	CcSEcCtD
Granisetron—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1B1—esophageal cancer	0.00116	0.00236	CbGpPWpGaD
Granisetron—CYP1A1—Biological oxidations—CYP26A1—esophageal cancer	0.00116	0.00235	CbGpPWpGaD
Granisetron—HTR3A—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.00116	0.00234	CbGpPWpGaD
Granisetron—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—esophageal cancer	0.00116	0.00234	CbGpPWpGaD
Granisetron—CYP2D6—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	0.00115	0.00233	CbGpPWpGaD
Granisetron—Chest pain—Methotrexate—esophageal cancer	0.00114	0.00262	CcSEcCtD
Granisetron—Arthralgia—Methotrexate—esophageal cancer	0.00114	0.00262	CcSEcCtD
Granisetron—CYP1A1—Metapathway biotransformation—CYP26A1—esophageal cancer	0.00114	0.00231	CbGpPWpGaD
Granisetron—CYP3A5—Biological oxidations—GSTO1—esophageal cancer	0.00114	0.00231	CbGpPWpGaD
Granisetron—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.00114	0.00261	CcSEcCtD
Granisetron—Discomfort—Methotrexate—esophageal cancer	0.00113	0.00259	CcSEcCtD
Granisetron—CYP3A5—Metapathway biotransformation—GSTO1—esophageal cancer	0.00113	0.00228	CbGpPWpGaD
Granisetron—CYP2D6—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	0.00111	0.00225	CbGpPWpGaD
Granisetron—Anaphylactic shock—Methotrexate—esophageal cancer	0.0011	0.00251	CcSEcCtD
Granisetron—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	0.00109	0.00222	CbGpPWpGaD
Granisetron—Infection—Methotrexate—esophageal cancer	0.00109	0.0025	CcSEcCtD
Granisetron—Hypersensitivity—Capecitabine—esophageal cancer	0.00109	0.00249	CcSEcCtD
Granisetron—CYP2D6—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	0.00108	0.00219	CbGpPWpGaD
Granisetron—CYP1A1—Biological oxidations—GSTO1—esophageal cancer	0.00108	0.00218	CbGpPWpGaD
Granisetron—Nervous system disorder—Methotrexate—esophageal cancer	0.00108	0.00247	CcSEcCtD
Granisetron—Thrombocytopenia—Methotrexate—esophageal cancer	0.00107	0.00246	CcSEcCtD
Granisetron—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—esophageal cancer	0.00107	0.00217	CbGpPWpGaD
Granisetron—CYP2D6—Biological oxidations—ADH7—esophageal cancer	0.00107	0.00217	CbGpPWpGaD
Granisetron—Skin disorder—Methotrexate—esophageal cancer	0.00107	0.00244	CcSEcCtD
Granisetron—CYP1A1—Metapathway biotransformation—GSTO1—esophageal cancer	0.00106	0.00215	CbGpPWpGaD
Granisetron—Hyperhidrosis—Methotrexate—esophageal cancer	0.00106	0.00243	CcSEcCtD
Granisetron—Asthenia—Capecitabine—esophageal cancer	0.00106	0.00242	CcSEcCtD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor—RB1—esophageal cancer	0.00105	0.00212	CbGpPWpGaD
Granisetron—Pruritus—Capecitabine—esophageal cancer	0.00104	0.00239	CcSEcCtD
Granisetron—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—esophageal cancer	0.00104	0.0021	CbGpPWpGaD
Granisetron—Hypotension—Methotrexate—esophageal cancer	0.00103	0.00235	CcSEcCtD
Granisetron—Diarrhoea—Capecitabine—esophageal cancer	0.00101	0.00231	CcSEcCtD
Granisetron—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.001	0.00229	CcSEcCtD
Granisetron—Insomnia—Methotrexate—esophageal cancer	0.000992	0.00227	CcSEcCtD
Granisetron—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—esophageal cancer	0.000987	0.002	CbGpPWpGaD
Granisetron—Paraesthesia—Methotrexate—esophageal cancer	0.000985	0.00226	CcSEcCtD
Granisetron—Dyspnoea—Methotrexate—esophageal cancer	0.000978	0.00224	CcSEcCtD
Granisetron—Somnolence—Methotrexate—esophageal cancer	0.000976	0.00224	CcSEcCtD
Granisetron—Dizziness—Capecitabine—esophageal cancer	0.000975	0.00223	CcSEcCtD
Granisetron—Dyspepsia—Methotrexate—esophageal cancer	0.000966	0.00221	CcSEcCtD
Granisetron—Decreased appetite—Methotrexate—esophageal cancer	0.000954	0.00219	CcSEcCtD
Granisetron—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CRABP1—esophageal cancer	0.000951	0.00192	CbGpPWpGaD
Granisetron—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000947	0.00217	CcSEcCtD
Granisetron—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—esophageal cancer	0.000944	0.00191	CbGpPWpGaD
Granisetron—CYP2D6—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.000943	0.00191	CbGpPWpGaD
Granisetron—CYP3A4—Tryptophan metabolism—CYP1B1—esophageal cancer	0.000941	0.00191	CbGpPWpGaD
Granisetron—CYP2D6—Biological oxidations—ADH1B—esophageal cancer	0.000939	0.0019	CbGpPWpGaD
Granisetron—Pain—Methotrexate—esophageal cancer	0.000938	0.00215	CcSEcCtD
Granisetron—Vomiting—Capecitabine—esophageal cancer	0.000937	0.00215	CcSEcCtD
Granisetron—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—esophageal cancer	0.000932	0.00189	CbGpPWpGaD
Granisetron—CYP3A5—Biological oxidations—ALDH2—esophageal cancer	0.00093	0.00188	CbGpPWpGaD
Granisetron—Rash—Capecitabine—esophageal cancer	0.000929	0.00213	CcSEcCtD
Granisetron—Dermatitis—Capecitabine—esophageal cancer	0.000929	0.00213	CcSEcCtD
Granisetron—Headache—Capecitabine—esophageal cancer	0.000923	0.00212	CcSEcCtD
Granisetron—HTR3A—SIDS Susceptibility Pathways—EP300—esophageal cancer	0.000912	0.00185	CbGpPWpGaD
Granisetron—Feeling abnormal—Methotrexate—esophageal cancer	0.000904	0.00207	CcSEcCtD
Granisetron—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000897	0.00206	CcSEcCtD
Granisetron—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.000887	0.0018	CbGpPWpGaD
Granisetron—CYP3A4—Tryptophan metabolism—CYP19A1—esophageal cancer	0.000885	0.00179	CbGpPWpGaD
Granisetron—CYP3A5—Biological oxidations—GSTT1—esophageal cancer	0.000885	0.00179	CbGpPWpGaD
Granisetron—CYP1A1—Biological oxidations—ALDH2—esophageal cancer	0.000879	0.00178	CbGpPWpGaD
Granisetron—Nausea—Capecitabine—esophageal cancer	0.000876	0.00201	CcSEcCtD
Granisetron—CYP3A5—Biological oxidations—CYP2A6—esophageal cancer	0.000874	0.00177	CbGpPWpGaD
Granisetron—CYP2D6—Biological oxidations—CYP26A1—esophageal cancer	0.000873	0.00177	CbGpPWpGaD
Granisetron—Urticaria—Methotrexate—esophageal cancer	0.000872	0.002	CcSEcCtD
Granisetron—Abdominal pain—Methotrexate—esophageal cancer	0.000867	0.00199	CcSEcCtD
Granisetron—Body temperature increased—Methotrexate—esophageal cancer	0.000867	0.00199	CcSEcCtD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—esophageal cancer	0.000862	0.00175	CbGpPWpGaD
Granisetron—CYP2D6—Metapathway biotransformation—CYP26A1—esophageal cancer	0.000861	0.00174	CbGpPWpGaD
Granisetron—CYP1A1—Biological oxidations—GSTT1—esophageal cancer	0.000836	0.00169	CbGpPWpGaD
Granisetron—CYP3A5—Biological oxidations—PTGS1—esophageal cancer	0.000829	0.00168	CbGpPWpGaD
Granisetron—CYP1A1—Biological oxidations—CYP2A6—esophageal cancer	0.000826	0.00167	CbGpPWpGaD
Granisetron—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—esophageal cancer	0.000814	0.00165	CbGpPWpGaD
Granisetron—CYP2D6—Biological oxidations—GSTO1—esophageal cancer	0.000811	0.00164	CbGpPWpGaD
Granisetron—Hypersensitivity—Methotrexate—esophageal cancer	0.000808	0.00185	CcSEcCtD
Granisetron—CYP1A1—Arachidonic acid metabolism—PTGS2—esophageal cancer	0.000806	0.00163	CbGpPWpGaD
Granisetron—CYP2D6—Metapathway biotransformation—GSTO1—esophageal cancer	0.0008	0.00162	CbGpPWpGaD
Granisetron—Asthenia—Methotrexate—esophageal cancer	0.000787	0.0018	CcSEcCtD
Granisetron—CYP1A1—Biological oxidations—PTGS1—esophageal cancer	0.000783	0.00159	CbGpPWpGaD
Granisetron—Pruritus—Methotrexate—esophageal cancer	0.000776	0.00178	CcSEcCtD
Granisetron—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—esophageal cancer	0.000765	0.00155	CbGpPWpGaD
Granisetron—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—esophageal cancer	0.000761	0.00154	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor—CDKN1A—esophageal cancer	0.000753	0.00153	CbGpPWpGaD
Granisetron—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	0.000751	0.00152	CbGpPWpGaD
Granisetron—Diarrhoea—Methotrexate—esophageal cancer	0.000751	0.00172	CcSEcCtD
Granisetron—Dizziness—Methotrexate—esophageal cancer	0.000726	0.00166	CcSEcCtD
Granisetron—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	0.000725	0.00147	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor—EP300—esophageal cancer	0.000717	0.00145	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EP300—esophageal cancer	0.000717	0.00145	CbGpPWpGaD
Granisetron—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	0.000715	0.00145	CbGpPWpGaD
Granisetron—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	0.000706	0.00143	CbGpPWpGaD
Granisetron—HTR3A—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000705	0.00143	CbGpPWpGaD
Granisetron—CYP3A5—Biological oxidations—CYP1B1—esophageal cancer	0.000705	0.00143	CbGpPWpGaD
Granisetron—CYP3A4—Biological oxidations—ADH7—esophageal cancer	0.0007	0.00142	CbGpPWpGaD
Granisetron—Vomiting—Methotrexate—esophageal cancer	0.000698	0.0016	CcSEcCtD
Granisetron—CYP3A5—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000695	0.00141	CbGpPWpGaD
Granisetron—Rash—Methotrexate—esophageal cancer	0.000692	0.00159	CcSEcCtD
Granisetron—Dermatitis—Methotrexate—esophageal cancer	0.000691	0.00158	CcSEcCtD
Granisetron—Headache—Methotrexate—esophageal cancer	0.000687	0.00158	CcSEcCtD
Granisetron—HTR3A—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000677	0.00137	CbGpPWpGaD
Granisetron—CYP1A1—Biological oxidations—CYP1B1—esophageal cancer	0.000666	0.00135	CbGpPWpGaD
Granisetron—CYP3A5—Biological oxidations—CYP19A1—esophageal cancer	0.000663	0.00134	CbGpPWpGaD
Granisetron—CYP2D6—Biological oxidations—ALDH2—esophageal cancer	0.000661	0.00134	CbGpPWpGaD
Granisetron—CYP1A1—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000657	0.00133	CbGpPWpGaD
Granisetron—CYP3A5—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000654	0.00132	CbGpPWpGaD
Granisetron—Nausea—Methotrexate—esophageal cancer	0.000652	0.00149	CcSEcCtD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.000642	0.0013	CbGpPWpGaD
Granisetron—CYP2D6—Biological oxidations—GSTT1—esophageal cancer	0.000629	0.00127	CbGpPWpGaD
Granisetron—CYP1A1—Biological oxidations—CYP19A1—esophageal cancer	0.000626	0.00127	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor—MYC—esophageal cancer	0.000625	0.00126	CbGpPWpGaD
Granisetron—CYP2D6—Biological oxidations—CYP2A6—esophageal cancer	0.000622	0.00126	CbGpPWpGaD
Granisetron—CYP1A1—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000617	0.00125	CbGpPWpGaD
Granisetron—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.000617	0.00125	CbGpPWpGaD
Granisetron—CYP3A4—Biological oxidations—ADH1B—esophageal cancer	0.000614	0.00124	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—esophageal cancer	0.000611	0.00124	CbGpPWpGaD
Granisetron—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—esophageal cancer	0.000611	0.00124	CbGpPWpGaD
Granisetron—CYP2D6—Biological oxidations—PTGS1—esophageal cancer	0.000589	0.00119	CbGpPWpGaD
Granisetron—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.00058	0.00117	CbGpPWpGaD
Granisetron—CYP3A4—Biological oxidations—CYP26A1—esophageal cancer	0.000571	0.00115	CbGpPWpGaD
Granisetron—CYP3A4—Metapathway biotransformation—CYP26A1—esophageal cancer	0.000563	0.00114	CbGpPWpGaD
Granisetron—CYP3A4—Biological oxidations—GSTO1—esophageal cancer	0.00053	0.00107	CbGpPWpGaD
Granisetron—CYP1A1—PPARA activates gene expression—CREBBP—esophageal cancer	0.000524	0.00106	CbGpPWpGaD
Granisetron—CYP3A4—Metapathway biotransformation—GSTO1—esophageal cancer	0.000523	0.00106	CbGpPWpGaD
Granisetron—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CREBBP—esophageal cancer	0.000513	0.00104	CbGpPWpGaD
Granisetron—CYP2D6—Biological oxidations—CYP1B1—esophageal cancer	0.000501	0.00101	CbGpPWpGaD
Granisetron—CYP2D6—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000494	0.001	CbGpPWpGaD
Granisetron—CYP2D6—Biological oxidations—CYP19A1—esophageal cancer	0.000471	0.000954	CbGpPWpGaD
Granisetron—CYP2D6—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000465	0.000941	CbGpPWpGaD
Granisetron—HTR3A—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000452	0.000916	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.000434	0.000878	CbGpPWpGaD
Granisetron—CYP3A4—Biological oxidations—ALDH2—esophageal cancer	0.000432	0.000875	CbGpPWpGaD
Granisetron—CYP3A4—Biological oxidations—GSTT1—esophageal cancer	0.000411	0.000833	CbGpPWpGaD
Granisetron—CYP3A4—Biological oxidations—CYP2A6—esophageal cancer	0.000407	0.000823	CbGpPWpGaD
Granisetron—CYP3A4—Biological oxidations—PTGS1—esophageal cancer	0.000385	0.00078	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.000379	0.000766	CbGpPWpGaD
Granisetron—CYP1A1—PPARA activates gene expression—EP300—esophageal cancer	0.000357	0.000723	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—SLC52A3—esophageal cancer	0.000356	0.000721	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—BLVRB—esophageal cancer	0.000356	0.000721	CbGpPWpGaD
Granisetron—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CREBBP—esophageal cancer	0.000353	0.000715	CbGpPWpGaD
Granisetron—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—esophageal cancer	0.000349	0.000707	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—BLVRB—esophageal cancer	0.000336	0.000681	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—SLC52A3—esophageal cancer	0.000336	0.000681	CbGpPWpGaD
Granisetron—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	0.000328	0.000663	CbGpPWpGaD
Granisetron—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000323	0.000654	CbGpPWpGaD
Granisetron—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	0.000308	0.000624	CbGpPWpGaD
Granisetron—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000304	0.000615	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—SLC10A2—esophageal cancer	0.000303	0.000613	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—CA1—esophageal cancer	0.000303	0.000613	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.000301	0.000609	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—CA1—esophageal cancer	0.000286	0.000579	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—SLC10A2—esophageal cancer	0.000286	0.000579	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—CA2—esophageal cancer	0.000277	0.000561	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—CA2—esophageal cancer	0.000262	0.00053	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—ADH7—esophageal cancer	0.000257	0.000521	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—PLCE1—esophageal cancer	0.000257	0.000521	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.000256	0.000518	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—SLC52A3—esophageal cancer	0.000253	0.000513	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—BLVRB—esophageal cancer	0.000253	0.000513	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—ADH7—esophageal cancer	0.000243	0.000492	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—PLCE1—esophageal cancer	0.000243	0.000492	CbGpPWpGaD
Granisetron—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—esophageal cancer	0.000241	0.000487	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	0.00024	0.000487	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—ADH1B—esophageal cancer	0.000226	0.000457	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—TYMP—esophageal cancer	0.000216	0.000437	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—SLC10A2—esophageal cancer	0.000215	0.000436	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—CA1—esophageal cancer	0.000215	0.000436	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—ADH1B—esophageal cancer	0.000213	0.000432	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—CYP26A1—esophageal cancer	0.00021	0.000425	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—ALOX15—esophageal cancer	0.000205	0.000414	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—TYMP—esophageal cancer	0.000204	0.000413	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—CYP26A1—esophageal cancer	0.000198	0.000401	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—CA2—esophageal cancer	0.000197	0.000399	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—GSTO1—esophageal cancer	0.000195	0.000395	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—TPI1—esophageal cancer	0.000195	0.000395	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—ALOX15—esophageal cancer	0.000193	0.000391	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—ALDOB—esophageal cancer	0.000187	0.000379	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—GSTO1—esophageal cancer	0.000184	0.000373	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—TPI1—esophageal cancer	0.000184	0.000373	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—PLCE1—esophageal cancer	0.000183	0.000371	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—ADH7—esophageal cancer	0.000183	0.000371	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—GAPDH—esophageal cancer	0.00018	0.000365	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—CRABP1—esophageal cancer	0.000178	0.000361	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—ALDOB—esophageal cancer	0.000177	0.000358	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—GAPDH—esophageal cancer	0.00017	0.000344	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—GNG7—esophageal cancer	0.00017	0.000344	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—CRABP1—esophageal cancer	0.000169	0.000341	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—SLC52A3—esophageal cancer	0.000166	0.000335	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—BLVRB—esophageal cancer	0.000166	0.000335	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—ADH1B—esophageal cancer	0.000161	0.000325	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—GNG7—esophageal cancer	0.00016	0.000325	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—ALDH2—esophageal cancer	0.000159	0.000322	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—TYMP—esophageal cancer	0.000153	0.000311	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—GSTT1—esophageal cancer	0.000151	0.000306	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—ALDH2—esophageal cancer	0.00015	0.000304	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—CYP2A6—esophageal cancer	0.00015	0.000303	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—CYP26A1—esophageal cancer	0.000149	0.000302	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—ALOX15—esophageal cancer	0.000145	0.000294	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—GSTT1—esophageal cancer	0.000143	0.000289	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—PTGS1—esophageal cancer	0.000142	0.000287	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—ENO1—esophageal cancer	0.000142	0.000287	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—CYP2A6—esophageal cancer	0.000141	0.000286	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—CA1—esophageal cancer	0.000141	0.000285	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—SLC10A2—esophageal cancer	0.000141	0.000285	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	0.000141	0.000285	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—PSME2—esophageal cancer	0.00014	0.000283	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—PSME1—esophageal cancer	0.00014	0.000283	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—GSTO1—esophageal cancer	0.000139	0.000281	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—TPI1—esophageal cancer	0.000139	0.000281	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—ENO1—esophageal cancer	0.000134	0.000271	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—PTGS1—esophageal cancer	0.000134	0.000271	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—ALDOB—esophageal cancer	0.000133	0.000269	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—PSME2—esophageal cancer	0.000132	0.000267	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—PSME1—esophageal cancer	0.000132	0.000267	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—CA2—esophageal cancer	0.000129	0.000261	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—GAPDH—esophageal cancer	0.000128	0.000259	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—CRABP1—esophageal cancer	0.000127	0.000257	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—GNG7—esophageal cancer	0.000121	0.000244	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—CYP1B1—esophageal cancer	0.000121	0.000244	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—PLCE1—esophageal cancer	0.00012	0.000242	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—ADH7—esophageal cancer	0.00012	0.000242	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	0.000115	0.000233	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—CYP1B1—esophageal cancer	0.000114	0.000231	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—CYP19A1—esophageal cancer	0.000113	0.000229	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—ALDH2—esophageal cancer	0.000113	0.000229	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—GSTT1—esophageal cancer	0.000108	0.000218	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—CYP19A1—esophageal cancer	0.000107	0.000217	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—CYP2A6—esophageal cancer	0.000106	0.000215	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—ADH1B—esophageal cancer	0.000105	0.000212	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—HMOX1—esophageal cancer	0.000103	0.000209	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—ENO1—esophageal cancer	0.000101	0.000204	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—PTGS1—esophageal cancer	0.000101	0.000204	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—TYMP—esophageal cancer	0.0001	0.000203	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—PSME2—esophageal cancer	9.93e-05	0.000201	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—PSME1—esophageal cancer	9.93e-05	0.000201	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—ABCB1—esophageal cancer	9.93e-05	0.000201	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—HMOX1—esophageal cancer	9.77e-05	0.000198	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—CYP26A1—esophageal cancer	9.76e-05	0.000198	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	9.58e-05	0.000194	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—ALOX15—esophageal cancer	9.51e-05	0.000192	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—ABCB1—esophageal cancer	9.38e-05	0.00019	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—TPI1—esophageal cancer	9.07e-05	0.000184	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—GSTO1—esophageal cancer	9.07e-05	0.000184	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—ALDOB—esophageal cancer	8.7e-05	0.000176	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—CYP1B1—esophageal cancer	8.57e-05	0.000174	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—GAPDH—esophageal cancer	8.37e-05	0.000169	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—CRABP1—esophageal cancer	8.3e-05	0.000168	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—CYP19A1—esophageal cancer	8.06e-05	0.000163	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—GNG7—esophageal cancer	7.89e-05	0.00016	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—ALDH2—esophageal cancer	7.39e-05	0.00015	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—HMOX1—esophageal cancer	7.35e-05	0.000149	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	7.09e-05	0.000144	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—ABCB1—esophageal cancer	7.06e-05	0.000143	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—GSTT1—esophageal cancer	7.03e-05	0.000142	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—CYP2A6—esophageal cancer	6.95e-05	0.000141	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—CREBBP—esophageal cancer	6.63e-05	0.000134	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—PTGS1—esophageal cancer	6.59e-05	0.000133	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—ENO1—esophageal cancer	6.59e-05	0.000133	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—PSME2—esophageal cancer	6.49e-05	0.000131	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—PSME1—esophageal cancer	6.49e-05	0.000131	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—CREBBP—esophageal cancer	6.27e-05	0.000127	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—NOS3—esophageal cancer	5.94e-05	0.00012	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—NOS3—esophageal cancer	5.61e-05	0.000114	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—CYP1B1—esophageal cancer	5.6e-05	0.000113	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—PTGS2—esophageal cancer	5.43e-05	0.00011	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—CYP19A1—esophageal cancer	5.27e-05	0.000107	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—PTGS2—esophageal cancer	5.13e-05	0.000104	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—HMOX1—esophageal cancer	4.81e-05	9.73e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—CREBBP—esophageal cancer	4.72e-05	9.55e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—ABCB1—esophageal cancer	4.61e-05	9.34e-05	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—EP300—esophageal cancer	4.52e-05	9.15e-05	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—EP300—esophageal cancer	4.27e-05	8.64e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—NOS3—esophageal cancer	4.22e-05	8.55e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—PTGS2—esophageal cancer	3.86e-05	7.82e-05	CbGpPWpGaD
Granisetron—CYP3A5—Metabolism—PIK3CA—esophageal cancer	3.34e-05	6.77e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—EP300—esophageal cancer	3.21e-05	6.5e-05	CbGpPWpGaD
Granisetron—CYP1A1—Metabolism—PIK3CA—esophageal cancer	3.16e-05	6.39e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—CREBBP—esophageal cancer	3.08e-05	6.24e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—NOS3—esophageal cancer	2.76e-05	5.59e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—PTGS2—esophageal cancer	2.53e-05	5.11e-05	CbGpPWpGaD
Granisetron—CYP2D6—Metabolism—PIK3CA—esophageal cancer	2.38e-05	4.81e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—EP300—esophageal cancer	2.1e-05	4.25e-05	CbGpPWpGaD
Granisetron—CYP3A4—Metabolism—PIK3CA—esophageal cancer	1.55e-05	3.15e-05	CbGpPWpGaD
